Research

Energy balance

Long-term data on the efficacy and safety of Tirzepatide are still forthcoming.

Practitioners should remain cautious and await further data on long-term outcomes before fully endorsing TZP.

LimitedQualifiesmedium confidence
While long-term data on efficacy and safety are still forthcoming.
Syed Arman Rabbani et al. · Expert Review of Endocrinology & Metabolism · 2024

Why this rating

The claim is based on expert opinion regarding future data.

Source

Tirzepatide: unveiling a new dawn in dual-targeted diabetes and obesity management

Syed Arman Rabbani et al. · Expert Review of Endocrinology & Metabolism · 2024

DOI 10.1080/17446651.2024.2395540

reviewCited 5×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →